Michael G. Wokasch

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ.

PanVera LLC develops protein drug targets and drug screening assays for high throughput screening. The company is headquartered in Madison, WI.

Part of Cardinal Health, Inc., Gala Biotech develops gene insertion technology to produce pharmaceutical proteins. The company is based in Middleton, WI. Gala Biotech was acquired by Cardinal Health, Inc. on October 01, 2003 for $15.50 million.

Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.